Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

IC-351 improves erectile response to visual stimulation in men with mild to moderate ED

Jan. 31, 2000

New formulation of Xatral receives European approvals

Jan. 28, 2000

Takeda files for ED treatment in Europe

Jan. 27, 2000

Novel, highly water soluble salt of sildenafil suitable for intranasal administration

Jan. 26, 2000

New inhibitors of cGMP-PDE in development at BMS for ED and cardiovascular conditions

Jan. 24, 2000

Melanocortin receptor agonists and their use disclosed by Merck

Jan. 21, 2000

Afferon steps up development of RTX for treatment of urge incontinence

Jan. 21, 2000

FemSoft Insert now commercially available in U.S. for treatment of incontinence

Jan. 19, 2000

Pharmacia & Upjohn and Searle to copromote Detrol

Jan. 11, 2000

FDA informs Urologix of new developments concerning the Targis System

Jan. 6, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...